423 related articles for article (PubMed ID: 11786023)
1. Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR).
Zhou M; Horita DA; Waugh DS; Byrd RA; Morrison DK
J Mol Biol; 2002 Jan; 315(3):435-46. PubMed ID: 11786023
[TBL] [Abstract][Full Text] [Related]
2. Domain shuffling as a tool for investigation of protein function: substitution of the cysteine-rich region of Raf kinase and PKC eta for that of yeast Pkc1p.
Schmitz HP; Jöckel J; Block C; Heinisch JJ
J Mol Biol; 2001 Aug; 311(1):1-7. PubMed ID: 11469853
[TBL] [Abstract][Full Text] [Related]
3. CK2 Is a component of the KSR1 scaffold complex that contributes to Raf kinase activation.
Ritt DA; Zhou M; Conrads TP; Veenstra TD; Copeland TD; Morrison DK
Curr Biol; 2007 Jan; 17(2):179-84. PubMed ID: 17174095
[TBL] [Abstract][Full Text] [Related]
4. Hypothesis: ceramide conditionally activates atypical protein kinases C, Raf-1 and KSR through binding to their cysteine-rich domains.
van Blitterswijk WJ
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):679-80. PubMed ID: 9531568
[No Abstract] [Full Text] [Related]
5. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites.
Ory S; Zhou M; Conrads TP; Veenstra TD; Morrison DK
Curr Biol; 2003 Aug; 13(16):1356-64. PubMed ID: 12932319
[TBL] [Abstract][Full Text] [Related]
6. A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation.
Yin X; Zafrullah M; Lee H; Haimovitz-Friedman A; Fuks Z; Kolesnick R
Cell Physiol Biochem; 2009; 24(3-4):219-30. PubMed ID: 19710537
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice.
Lozano J; Xing R; Cai Z; Jensen HL; Trempus C; Mark W; Cannon R; Kolesnick R
Cancer Res; 2003 Jul; 63(14):4232-8. PubMed ID: 12874031
[TBL] [Abstract][Full Text] [Related]
8. Identification of key residues in the A-Raf kinase important for phosphoinositide lipid binding specificity.
Johnson LM; James KM; Chamberlain MD; Anderson DH
Biochemistry; 2005 Mar; 44(9):3432-40. PubMed ID: 15736953
[TBL] [Abstract][Full Text] [Related]
9. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family.
Chen J; Deng F; Li J; Wang QJ
Biochem J; 2008 Apr; 411(2):333-42. PubMed ID: 18076381
[TBL] [Abstract][Full Text] [Related]
10. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A
Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the C1A and C1B domains to the membrane interaction of protein kinase C.
Giorgione J; Hysell M; Harvey DF; Newton AC
Biochemistry; 2003 Sep; 42(38):11194-202. PubMed ID: 14503869
[TBL] [Abstract][Full Text] [Related]
12. PKC gamma mutations in spinocerebellar ataxia type 14 affect C1 domain accessibility and kinase activity leading to aberrant MAPK signaling.
Verbeek DS; Goedhart J; Bruinsma L; Sinke RJ; Reits EA
J Cell Sci; 2008 Jul; 121(Pt 14):2339-49. PubMed ID: 18577575
[TBL] [Abstract][Full Text] [Related]
13. Differential membrane binding and diacylglycerol recognition by C1 domains of RasGRPs.
Johnson JE; Goulding RE; Ding Z; Partovi A; Anthony KV; Beaulieu N; Tazmini G; Cornell RB; Kay RJ
Biochem J; 2007 Sep; 406(2):223-36. PubMed ID: 17523924
[TBL] [Abstract][Full Text] [Related]
14. Structure of the C2 domain from novel protein kinase Cepsilon. A membrane binding model for Ca(2+)-independent C2 domains.
Ochoa WF; Garcia-Garcia J; Fita I; Corbalan-Garcia S; Verdaguer N; Gomez-Fernandez JC
J Mol Biol; 2001 Aug; 311(4):837-49. PubMed ID: 11518534
[TBL] [Abstract][Full Text] [Related]
15. Two phosphorylation-independent sites on the p85 SH2 domains bind A-Raf kinase.
Fang Y; Johnson LM; Mahon ES; Anderson DH
Biochem Biophys Res Commun; 2002 Feb; 290(4):1267-74. PubMed ID: 11812000
[TBL] [Abstract][Full Text] [Related]
16. Kinase suppressor of RAS (KSR) amplifies the differentiation signal provided by low concentrations 1,25-dihydroxyvitamin D3.
Wang X; Studzinski GP
J Cell Physiol; 2004 Mar; 198(3):333-42. PubMed ID: 14755538
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of the C-terminal hypervariable region of K-Ras4B in plasma membrane targetting and transformation.
Welman A; Burger MM; Hagmann J
Oncogene; 2000 Sep; 19(40):4582-91. PubMed ID: 11030147
[TBL] [Abstract][Full Text] [Related]
18. Protein-protein recognition: an experimental and computational study of the R89K mutation in Raf and its effect on Ras binding.
Zeng J; Fridman M; Maruta H; Treutlein HR; Simonson T
Protein Sci; 1999 Jan; 8(1):50-64. PubMed ID: 10210183
[TBL] [Abstract][Full Text] [Related]
19. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity.
Kim M; Yan Y; Kortum RL; Stoeger SM; Sgagias MK; Lee K; Lewis RE; Cowan KH
Cancer Res; 2005 May; 65(10):3986-92. PubMed ID: 15899786
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the cysteine-rich domain of the Escherichia coli chaperone protein DnaJ.
Martinez-Yamout M; Legge GB; Zhang O; Wright PE; Dyson HJ
J Mol Biol; 2000 Jul; 300(4):805-18. PubMed ID: 10891270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
